Scientists found that overexpressed TGF-β causes a plethora of metabolic disorders and dysfunction and promotes epithelial-mesenchymal transition (EMT) and excessive deposition of ECM [5, 6], which causes fibrosis [7]. This evidence concerns the gene TGFB1 and metabolic disease.